More Chimeric Therapeutics Limited news
Chimeric Therapeutics LimitedASX: CHM

75% disease control observed in CHM CDH17 trial

Nov 13, 2025 at 4:43 AM UTC · Issued by Chimeric Therapeutics Limited

Chimeric Therapeutics Ltd has released a press release.

View Attachment